Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (CRBP)

Q: What does CUSIP 21833P301 represent in this 13F holders report?

CUSIP 21833P301 is the security identifier for CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share in Q1 2025?

85 institutional investors reported CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share for Q1 2025. Use the holders table for investor-level position and value details.

CUSIP: 21833P301

Q1 2025 13F Holders as of 31 Mar 2025

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 10,430,351
Total 13F value: $55,391,632
Share change: -517,503
Put/Call ratio: 304%
SEC-reported price per share: $5.31
Number of holders: 85
Value change: -$13,394,437
Number of buys: 38
Number of sells: 51
Shares outstanding: 19,341,293

Security key

21833P301

Report period

Q1 2025

Institutions

Top holders

CRBP full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Corbus Pharmaceuticals Holdings, Inc. SEC filings Corbus Pharmaceuticals Holdings, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 21833P301

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of CRBP - Corbus Pharmaceuticals Holdings, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ORBIMED ADVISORS LLC

Disclosed value leader

Cormorant Asset Managemen...

Comparable rows

1/15

Latest evidence

31 Dec 2024

13F 13D/G 3/4/5 Lead comparable stake: 5.9% 14 rows are not safely comparable across share classes. 13D/G row: ORBIMED ADVISORS LLC Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 5.9%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.

Comparable ownership Top 1

ORBIMED ADVISORS LLC 5.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F 13D/G Company · OrbiMed Capital LLC 13F 13D/G	5.9% Reported 13D/G · 31 Dec 2024	$13,832,987 1,172,287 shares	—	31 Dec 2024
Cormorant Asset Management, LP	13F Company 13F	— denominator unverified	$28,025,000 2,375,000 shares	—	31 Dec 2024
Octagon Capital Advisors LP	13F Company 13F	— denominator unverified	$13,157,000 1,115,000 shares	—	31 Dec 2024
BlackRock, Inc.	13F Company 13F	— denominator unverified	$10,305,814 873,374 shares	—	31 Dec 2024
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$7,778,584 659,202 shares	—	31 Dec 2024
Rachael Louise Brake	3/4/5 Chief Scientific Officer 3/4/5	— denominator unverified	$6,958,000 1,400,000 shares	—	13 Feb 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

10,430,351

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Holder diff

Investor	Q1 2025 Shares	Q1 2025 Shares	Share Diff	Share Chg %	Q1 2025 value	Q1 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend